Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Diabetes often causes various skin problems and complications.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Aromatic plants can naturally help prevent skin aging and improve skin health.

New acne treatments show promise as alternatives to traditional therapies.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Juniperus plants contain compounds with potential for developing various medical treatments.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Using longer PEG chains helps nanoparticles penetrate hair follicles better, improving drug delivery for conditions like alopecia.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Medicinal plants may be an effective alternative for treating acne.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Older people at home often have skin issues, but there's little evidence on how to prevent or treat them effectively.

PRP is effective for hair loss and might work better with other treatments, but more research is needed.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.